Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Capital Performance Advisors LLP Increases Stake in Pfizer Inc.

February 26, 2025
Capital Performance Advisors LLP has purchased additional shares of Pfizer Inc. (NYSE: PFE), according to recent reports. The investment firm acquired these shares due to the positive outlook on the company's future. Pfizer Inc. is one of the leading pharmaceutical companies globally, known for its innovative and diverse healthcare products. Analysts have also labeled Pfizer Inc. as a low-cost stock with long-term investment potential. With the recent increase in stake by Capital Performance Advisors LLP, it indicates the growing confidence among investors in Pfizer Inc. and its ability to deliver consistent returns. It is advised to seek professional guidance from Stocks Prognosis for a well-informed decision on the stock's movement.
If you want to leave a comment, then you need Login or Register





Other data for PFE

Related data

PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast With 10.06% Profit, Boosting QuantWave's Analytics  ~1 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at $23.03....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 8.56% Profit Achieved  ~1 min.

On May 2, 2025, QuantWave issued a price target forecast for PFIZER INC. with a signal to go long at $23.34. The predicted direction was realized on July 10, 2025, when the stock reached $25....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.57% Profit: A Success Story for QuantWave Analytics  ~2 min.

On June 27, 2025, QuantWave, the automated forecasting platform, released a price target forecast for PFIZER INC., signaling a long position with the stock trading at $23.78....


PFEJuly 10, 2025PFIZER INC. Stock Hits Forecast Price Target with 6.27% Profit: A Success Story for QuantWave  ~2 min.

In a recent market development, PFIZER INC. stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 6.27%....


PFEJuly 10, 2025PFIZER INC. Hits Price Target with 6.35% Profit: A Success Story for QuantWave Forecasting  ~1 min.

PFIZER INC. has recently hit the price target forecasted by QuantWave, achieving a profit of 6.35% for investors. The forecast signal was generated on June 26, 2025, with a price of 23.83 $....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.09% Profit: QuantWave Analysis  ~1 min.

On June 10, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.89. Fast forward to July 10, 2025, and the price target of $25....


PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.05% Profit  ~1 min.

On June 24, 2025, QuantWave issued a long signal for PFIZER INC. stock when it was trading at $23.9. Analysts predicted a target price of $25....


PFEJuly 10, 2025PFIZER INC. Hits Forecast Price Target with 7.55% Profit Margin  ~1 min.

On June 20, 2025, QuantWave's automated forecasting platform signaled a long position for PFIZER INC. (NYSE: PFE) with a price of 23.56 $....


PFEJuly 8, 2025PFIZER INC. Hits QuantWave Price Target Forecasts with Profit of 6.75%  ~2 min.

In the latest achievement for QuantWave's forecasting platform, the stock of PFIZER INC. successfully reached the price target as predicted....


PFEJuly 8, 2025PFIZER INC. Hits QuantWave Forecast Target with 7.29% Profit  ~1 min.

PFIZER INC. has successfully achieved the price target forecast set by QuantWave, signaling a significant 7.29% profit for investors....


REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....


ABBVDecember 2, 2024AbbVie Inc. ABBV: Leading Pharmaceutical Company Set to Present at Citi's Global Healthcare Conference  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, is gearing up to make a significant appearance at Citis 2024 Global Healthcare Conference....


PFENovember 20, 2024Pfizer Inc. Highlights Strategic Vision at London Healthcare Conference  ~1 min.

Pfizer Inc., a leading pharmaceutical company, is set to present its strategic vision at the upcoming Jefferies London Healthcare Conference....


LLYJanuary 9, 2025Eli Lilly and Company LLY Announces Participation in J.P. Morgan Healthcare Conference  ~1 min.

Eli Lilly and Company, a global pharmaceutical corporation, has recently confirmed their participation in the upcoming J.P. Morgan Healthcare Conference....


REGNJanuary 1, 2025Regeneron Pharmaceuticals Inc. Shows Impressive 89% Return for Investors  ~1 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been making significant strides in the pharmaceutical industry, resulting in a decent 89% return for its investors over the last five years....